The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Nussbaum Robert L since 2017.
This trader's CIK number is 1640322.
At the time of last reporting, Nussbaum Robert L was the Chief Medical Officer of Invitae Corp. (stock ticker symbol NVTA).
Also see all insider trading activities at Invitae Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | NVTA | 0 | $0 | 36,187 | $45,202 | 0 | $0 |
| 2022 | NVTA | 0 | $0 | 32,734 | $186,285 | 0 | $0 |
| 2021 | NVTA | 0 | $0 | 78,975 | $2,281,626 | 41,442 | $400,776 |
| 2020 | NVTA | 0 | $0 | 109,448 | $3,001,711 | 26,550 | $262,845 |
| 2019 | NVTA | 0 | $0 | 32,871 | $721,488 | 10,000 | $99,000 |
| 2018 | NVTA | 0 | $0 | 6,702 | $46,645 | 0 | $0 |
| 2017 | NVTA | 0 | $0 | 1,686 | $16,067 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-13 | NVTA | Sale | 7,086 | 1.38 | 9,757 |
| 2023-05-16 | NVTA | Sale | 26,476 | 1.20 | 31,744 |
| 2023-03-13 | NVTA | Sale | 2,625 | 1.41 | 3,701 |
| 2022-08-16 | NVTA | Sale | 7,048 | 4.55 | 32,068 |
| 2022-05-17 | NVTA | Sale | 6,098 | 3.81 | 23,233 |
| 2022-03-14 | NVTA | Sale | 19,588 | 6.69 | 130,984 |
| 2021-11-11 | NVTA | Sale | 29,675 | 21.89 | 649,556 |
| 2021-11-11 | NVTA | Option Ex | 29,675 | 10.06 | 298,678 |
| 2017-01-03 | NVTA | Option Ex | 1,666 | 1.26 | 2,099 |
| 2021-08-16 | NVTA | Sale | 21,231 | 25.42 | 539,628 |
| 2021-06-14 | NVTA | Sale | 9,910 | 31.62 | 313,403 |
| 2021-03-12 | NVTA | Sale | 18,159 | 42.90 | 779,039 |
| 2021-01-06 | NVTA | Option Ex | 10,101 | 9.90 | 99,999 |
| 2020-10-09 | NVTA | Option Ex | 6,550 | 9.90 | 64,845 |
| 2020-09-10 | NVTA | Sale | 23,175 | 33.85 | 784,404 |
| 2020-08-19 | NVTA | Sale | 19,049 | 32.10 | 611,396 |
| 2020-07-09 | NVTA | Sale | 29,783 | 34.21 | 1,018,757 |
| 2020-06-03 | NVTA | Option Ex | 20,000 | 9.90 | 198,000 |
| 2020-05-20 | NVTA | Sale | 6,864 | 16.70 | 114,635 |
| 2020-05-22 | NVTA | Sale | 19,893 | 17.42 | 346,555 |
| 2020-03-16 | NVTA | Sale | 10,684 | 11.79 | 125,964 |
| 2019-08-19 | NVTA | Sale | 20,447 | 25.29 | 517,186 |
| 2019-05-20 | NVTA | Sale | 7,202 | 18.21 | 131,148 |
| 2019-03-08 | NVTA | Option Ex | 10,000 | 9.90 | 99,000 |
| 2019-01-10 | NVTA | Sale | 5,222 | 14.01 | 73,154 |
| 2018-05-15 | NVTA | Sale | 6,702 | 6.96 | 46,645 |
| 2017-02-15 | NVTA | Sale | 1,686 | 9.53 | 16,067 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nussbaum Robert L (Chief Medical Officer of Invitae Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.